World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-COC-14005302
Date of registration: 2014-01-05
Prospective Registration: No
Primary sponsor: First Affiliated Hospital, College of Medicine, Zhejiang University
Public title: Study of the neuropsychology and neuroimaging in First-episode Schizophrenic Patients before and after treatment
Scientific title: Study of the neuropsychology and neuroimaging in First-episode Schizophrenic Patients
Date of first enrolment: 2011-11-01
Target sample size: Two groups:100;
Recruitment status: Completed
URL:  http://www.chictr.org.cn/showproj.aspx?proj=9603
Study type:  Cause
Study design:  Case-Control study  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Huang Manli   
Address:  No. 79, Qingchun Road, Hangzhou, Zhejiang, China
Telephone: +86 13957162975
Email: hml1208@sina.com
Affiliation: 
Name: Huang Manli   
Address:  No. 79, Qingchun Road, Hangzhou, Zhejiang, China
Telephone: +86 13957162975
Email: hml1208@sina.com
Affiliation:  First Affiliated Hospital, College of Medicine, Zh
Key inclusion & exclusion criteria
Inclusion criteria: Study group:
1. patients provided their written and informed consent;
2. patients were between 13-45 years old, males and females;
3. patients with a DSM-IV clinical criteria for Schizophrenic episode;
4. right-handed;
5. patients who are experiencing their first depressive episode and did not use the antipsychotic drug.
Control Group:
1. patients provided their written and informed consent;
2. patients were between 13-45 years old, males and females;
3. right-handed;
4. did not use the antipsychotic drug;
5. healthy.

Exclusion criteria: Patients were excluded if they fell into any of the following categories:
1. had epileptic, Body metal patients and cerebral apoplexy;
2. had severe nerve, heart, liver, kidney, endocrine, blood system diseases or other disturb the estimate of study;
3. had organic mental disorders and mental retardation;
4. had drugs, alcohol or other psychotropic active substance abusers;
5. Pregnant and lactating women.


Age minimum: 18
Age maximum: 45
Gender:
Health Condition(s) or Problem(s) studied
Schizophrenic
Intervention(s)
Two groups:neuropsychological test ;
Primary Outcome(s)
cognitive function;functional connectivity within default state netwo;the brain gray matter density;fractional anisotropy (FA) valus;regional homogeneity (ReHo) valus;PANSS score;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
The Zhejiang Science and Technology Agency key scientific and technological innovation projects(Y201
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history